Status:
COMPLETED
Pretreatment With Estradiol Valerate
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Infertility
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
The present study is set up to evaluate the efficacy of a programmation by administration of estrogen valerate during 6 or more consecutive days. In this prospective randomised trial, we study the imp...
Detailed Description
See Section Interventions
Eligibility Criteria
Inclusion
- \< 36 years old on day of randomisation FSH \< 12 (in the early follicular phase) Normal ultrasound scan, i.e. presence of both ovaries, without evidence of abnormality within 6 months prior to randomisation.
- Regular menstrual cycles of 21-35 days, presumed to be ovulatory. BMI between 18 and 29 (both inclusive) 1st or 2nd trial IVF or ICSI
Exclusion
- ≥ 36 years old on day of randomisation Endometriosis ≥ grade 3 PCOS Poor responders (development of \< 4 follicles in a previous IVF/ICSI cycle) Endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney)
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01218386
Start Date
May 1 2010
End Date
January 1 2012
Last Update
March 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel, Centre for Reproductive Medicine
Brussels, Belgium, 1090